Unique ID issued by UMIN | UMIN000011945 |
---|---|
Receipt number | R000013948 |
Scientific Title | Phase 1/2 clinical trial of a sustained- release lidocaine sheet for postoperative pain |
Date of disclosure of the study information | 2014/01/01 |
Last modified on | 2017/04/05 10:50:35 |
Phase 1/2 clinical trial of a sustained- release lidocaine sheet for postoperative pain
Phase 1/2 clinical trial of a sustained- release lidocaine sheet for postoperative pain
Phase 1/2 clinical trial of a sustained- release lidocaine sheet for postoperative pain
Phase 1/2 clinical trial of a sustained- release lidocaine sheet for postoperative pain
Japan | Asia(except Japan) |
the mandibular horizontal impacted wisdom tooth
Anesthesiology | Operative medicine | Dental medicine |
Others
NO
The aim of this clinical trial was to evaluate the safety and efficacy of a sustained-release lidocaine sheet for the pain in a patient after tooth extraction.
Safety,Efficacy
Phase I,II
VAS, pain-killer rescue postoperatively and patient satisfaction are compared with those of controled group.
VAS, pain-killer rescue postoperatively and patient satisfaction are compared with those of non-administration group.
Interventional
Parallel
Randomized
Individual
Single blind -participants are blinded
Placebo
Central registration
5
Treatment
Medicine |
Non-administration
Pracebo-Control
Poly (Lactic-co-Glycolic Acid) 100mg
a sustained- release lidocaine sheet (SRLS) 100mg
the SRLS 200mg (100mg*2)
the SRLS 400mg (100mg*4)
20 | years-old | <= |
50 | years-old | > |
Male and Female
1)Elective operation
2)ASA-PS 1, 2
3)Extraction of the mandibular horizontal impacted wisdom tooth
4)Obtaining an agreement of document about this study
1)A person taking a drug (e.g. antipsychotic, NSAIDs, and opioid) considered to participate in pain relief or judged that the influence is left even if canceled
2)A patient whose surgical site infects remarkably
3)A patient who has an allergy to Lidocaine, an amide type local anaesthetic agent, Celecoxib, a sulfonamide, Acetaminophen
4)A patient with a serious disturbance of conduction system (e.g. complete atrioventricular block)
5)A patient with peptic ulcer or asthma
6)A patient who has disturbance of consciousness or not able to communicate enough to evaluate correctly
7)A patient who is judged unsuitable for this trial by attending doctor
100
1st name | |
Middle name | |
Last name | Toshiyuki SUZUKI |
Gunma University Hospital
Department Of Anesthesiology
3-39-15 Showa-machi, Maebashi-shi Gunma371-8511, Japan
027-220-8454
toshis_free-hospital@yahoo.co.jp
1st name | |
Middle name | |
Last name | Toshiyuki SUZUKI |
Gunma University Hospital
Department Of Anesthesiology
3-39-15 Showa-machi, Maebashi-shi Gunma371-8511, Japan
027-220-8454
toshis_free-hospital@yahoo.co.jp
Department Of Anesthesiology
Gunma University graduate School of Medicine
The Japan Society for the Promotion of Science
Japan
Department of Anesthesiology and Intensive Care, Padjadjaran University
NO
群馬大学医学部附属病院(群馬県)
Hasan Sadikin Hospital/Medical Faculty, Padjadjaran University (Bandung, Indonesia)
2014 | Year | 01 | Month | 01 | Day |
Partially published
Completed
2014 | Year | 03 | Month | 24 | Day |
2014 | Year | 03 | Month | 27 | Day |
2017 | Year | 01 | Month | 05 | Day |
2017 | Year | 03 | Month | 31 | Day |
2017 | Year | 03 | Month | 31 | Day |
2013 | Year | 10 | Month | 02 | Day |
2017 | Year | 04 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013948